A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
about
Optimal management of genital herpes: current perspectivesMathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaDiagnosis and treatment of viral encephalitisHerpes Genitalis: Diagnosis, Treatment and PreventionAntiviral drug resistance: mechanisms and clinical implicationsAlkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistanceCoresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase.Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.Medical and virological aspects of ocular human immunodeficiency virus infection for the ophthalmologist.Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome.New concepts in understanding genital herpes.Improving the care of patients with genital herpes.Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementManagement of herpes simplex and varicella-zoster virus infectionsChronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.Sexually transmitted diseases treatment guidelines, 2015.Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral ResistanceHerpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyOral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread.Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.Foscarnet alters antidiuretic hormone-mediated transport.Treatment of herpesvirus infections in HIV-infected individuals.Resistance of herpesviruses to antiviral drugsA net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virusThe use of antiviral drugs during the neonatal periodTopical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.Antiviral therapy: current concepts and practicesAnti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingAcyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus.Interactions and management issues in HSV and HIV coinfection.
P2860
Q26746041-E9837E99-4109-490C-8C7E-5D48E395C4F7Q27347896-11C98F38-836C-47BC-A9B0-EF7EE9DB2F15Q27477894-2FD7A1FC-5F15-4552-9812-D65FE6FDFDDDQ28067618-51FC5A6D-1B8D-48A8-8362-C0945663EA29Q28282376-6F66D86E-C796-4DE1-B4BE-7874A4A9FF3FQ28365182-54C843B7-F001-49BF-AB05-329A9446DF69Q28369167-1475A73F-8832-48AD-BC55-51D3B1782900Q30831284-F4F3F6AA-7206-429F-96D4-A010C76E9DCFQ33569593-036022F1-25B1-47F7-B285-AEB27A9777C7Q33569740-51A54D53-8537-4122-975D-6335D753BAA0Q33582145-F73DEE84-D752-4FCC-B4EB-339AEC9C7868Q33801850-4B5B3928-42FD-4A25-834B-A739252767B2Q33815823-F39002C2-A07A-41C2-8B57-655FAA30EF8EQ33936909-58280035-C15D-4F27-8BCA-D5FED7F280F3Q33966906-1F31BA65-AA20-44FC-B4FA-87EEFFCE5BCDQ33978415-76CF244A-9BF6-41CC-B60B-621E76E80375Q34149904-85D09B15-C31B-4F9F-8E50-5187C0E27D94Q34185463-59FEACBF-5414-4067-ABF4-354C9AD33FDEQ34459279-3F48FAC6-97F3-4B2D-B4FE-66AAFFD5FC46Q34464333-73CD47E6-3FFB-4E95-9502-A285B3142DE6Q34479272-EFC020FD-5CBD-4BCB-A87C-9AF1B93E36DFQ34479800-A485E9BA-33BA-4069-AAD3-3955960616B5Q34579981-99F5181A-1867-4621-B536-B00F751BA2A8Q35014240-6965C3C9-6AA9-4A34-A268-66C5ECFAB5ACQ35076909-06646451-7F78-4D73-ABA9-4E41ADF6695EQ35115200-9BAE1074-754A-43AE-A1C2-CD4E58B0745DQ35118306-B722D7D9-4088-4780-81D8-8405591946F2Q35231928-46AD47DF-EF2D-40D9-9717-4084FB8C588BQ35447500-4E20124F-FD45-4A97-85C8-3EB242E97D02Q35462273-E59BB383-2118-4ECB-92D1-BEB259660ECBQ35535201-2E042F20-2528-40E2-A57A-7CC3863E981AQ35789702-5C3067ED-CBA8-4152-A607-0A507239D6ABQ35814104-C37A9E5E-3A3C-4332-B170-BCD98CA2349BQ35821379-6917D5AF-84EF-42F2-8F3D-8CDD00092296Q35870930-3410CEAE-8B88-4324-BC9A-074AFB7DFF98Q36070394-BF6A537B-E4B8-45F5-A5C0-3034B3B75329Q36198298-C82586FB-A822-4FC1-ACE6-CBA7E29A03ACQ36630996-29D29AD9-3341-45AF-ABA1-B540CB19AA1CQ36729136-22984390-D412-46CA-8622-95C2AF698011Q36777844-68218BF4-8EC6-42D5-BA86-87FC22207E4E
P2860
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@en
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@nl
type
label
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@en
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@nl
prefLabel
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@en
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@nl
P2093
P1476
A controlled trial comparing f ...... he AIDS Clinical Trials Group.
@en
P2093
Crumpacker C
Kessler HA
P304
P356
10.1056/NEJM199108223250805
P407
P577
1991-08-01T00:00:00Z